CVS Health CVS
Price chart
Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.
Community Sentiment on CVS
Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Strategy Backtest
Pick a strategy above and run the backtest to see its simulated performance on CVS.
Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.
CVS at a glance
CVS Health (CVS) is trading at $85.25, up 1.67% on the day. Its market value of $109.08B makes it the 188th largest of the 3753 companies we follow.
Over the past 52 weeks it has traded between $67.99 and $109.22, so it sits 21.9% below the top of that range. Holders are ahead 10.4% over twelve months, but down 10.9% across the last three months.
On the chart it has slipped under both the 50-day ($90.37) and 200-day ($88.36) moving averages; RSI is 40, and the last 30 sessions moved at roughly 47% annualized volatility.
In the quarter ended Jun 2026 the company brought in $106.10B of revenue, up 7.3% from a year earlier, with $3.00B of net profit (a 1.2% margin).
The stock changes hands at 9.9 times trailing earnings, 69% below its five-year average of 32.3. The median for its industry group is 23.6.
16 analysts follow the stock and the average call is "buy". The mean target, $111.25, sits 30.5% over where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
BeStock Grade
Composite of 4 factors below, ranked against the 3740 U.S. stocks BeStock covers.
Cheaper than usual on its own 5-year P/E history scores higher.
Higher trailing yield than most of BeStock’s coverage scores higher.
Trading closer to its 52-week high than most peers scores higher.
16 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
BeStock Momentum
CVS is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-12-28, the strategy has returned 442.5% (211.9% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.
Price forecast
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $111.25, 30.5% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $110.00, so shares trade 22.5% below that estimate. On earnings multiple, it sits in the 67th percentile of its own five-year valuation range (pricier than usual).
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
CVS Health: the business
CVS owns Aetna health insurance, CVS pharmacies and the Caremark pharmacy benefit manager.
What tends to move it. Medical cost trends in Aetna's Medicare business and pharmacy reimbursement changes drive the stock.
Where the case gets weaker. Medical costs in the Medicare Advantage business have already surprised to the upside once, and a repeat would hit earnings hard, while further cuts to pharmacy reimbursement rates would pressure the Caremark and retail segments together.
Written by hand by the BeStock desk and revised when a business changes. how we work. Spot something out of date? Tell us.
Performance
Price return over each window, from adjusted daily and weekly closes
Technical signals
| Indicator | Value | Signal |
|---|---|---|
| Price vs 20-day average | -5.2% | Bearish |
| Price vs 50-day average | -5.7% | Bearish |
| Price vs 200-day average | -3.5% | Bearish |
| 50-day vs 200-day | 50d above 200d | Bullish |
| RSI (14) | 40.1 | Bearish |
| MACD (12,26,9) | -1.60 | Bearish |
| Bollinger band position | 22% | Bearish |
Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.
Key statistics
Quote as of Nov 9, 2026 10:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.
How CVS ranks on BeStock
Ranks are among the 3,740 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
Set against the peer table: at 9.9x earnings, CVS looks cheap against the market, and trades 58% below the 23.6x median among Healthcare Plans names. The two comparisons do not always agree.
CVS stock: common questions
What is CVS's latest share price?
$85.25 is the latest print for CVS, a move of +1.67% against yesterday's close of $83.85. Today's low and high so far: $83.83 and $85.75.
How large is CVS Health by market value?
Equity value comes to $109.08B at the current price. By that measure it is number 188 of the 3753 names in our coverage.
What multiple of earnings does CVS sell for?
Buyers pay 9.9 times the last twelve months of profit (EPS $1.39). Averaged over five years the multiple has been 32.3, and today's level ranks in the 67th percentile of its own history.
What's the 52-week trading range for CVS Health?
The year's floor is $67.99 and the ceiling $109.22. Shares are 21.9% away from that ceiling.
What's the dividend situation for CVS?
It does. Payouts over the past twelve months work out to a 3.12% yield; the latest ex-dividend date was October 22, 2026.
What are analysts saying about CVS?
Of 16 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $111.25, with the most cautious at $100.00 and the most optimistic at $123.00.
In plain terms, what does CVS Health sell?
CVS owns Aetna health insurance, CVS pharmacies and the Caremark pharmacy benefit manager.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on CVS.
Sign in to join the discussion.